These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 3459341

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ, Kircik LH.
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis].
    Zaun H, Luszpinski P.
    Z Hautkr; 1984 Sep 15; 59(18):1209-17. PubMed ID: 6388169
    [Abstract] [Full Text] [Related]

  • 6. [Contact allergy to the antifungal agent naftifin].
    Hoting E, Küchmeister B, Hausen BM.
    Derm Beruf Umwelt; 1987 Sep 15; 35(4):124-7. PubMed ID: 2959458
    [Abstract] [Full Text] [Related]

  • 7. The use of naftifine (Exoderil) cream in the treatment of dermatophytosis.
    Lee CT, Giam YC, Tan T.
    Singapore Med J; 1987 Oct 15; 28(5):429-31. PubMed ID: 3324355
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Double blind, randomized in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine (author's transl)].
    Hantschke D, Reichenberger M.
    Mykosen; 1980 Dec 15; 23(12):657-68. PubMed ID: 7012610
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses.
    Monk JP, Brogden RN.
    Drugs; 1991 Oct 15; 42(4):659-72. PubMed ID: 1723367
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy of naftifine, oxiconazole, and terbinafine in short-term treatment of tinea pedis.
    Ablon G, Rosen T, Spedale J.
    Int J Dermatol; 1996 Aug 15; 35(8):591-3. PubMed ID: 8854165
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and structure-activity relationships of naftifine-related allylamine antimycotics.
    Stütz A, Georgopoulos A, Granitzer W, Petranyi G, Berney D.
    J Med Chem; 1986 Jan 15; 29(1):112-25. PubMed ID: 3510297
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis).
    Saple DG, Amar AK, Ravichandran G, Korde KM, Desai A.
    J Indian Med Assoc; 2001 May 15; 99(5):274-5. PubMed ID: 11676116
    [Abstract] [Full Text] [Related]

  • 16. [Terbinafine (Lamisil)].
    Breton MC.
    Union Med Can; 1995 Nov 15; 124(3):20-5. PubMed ID: 8560634
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of dermatomycosis with naftifin. Therapeutic effectiveness following once and twice daily administration].
    Meinicke K, Striegel C, Weidinger G.
    Mykosen; 1984 Dec 15; 27(12):608-14. PubMed ID: 6395017
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fungicidal activity plus reservoir effect allow short treatment courses with terbinafine in tinea pedis.
    Schäfer-Korting M, Schoellmann C, Korting HC.
    Skin Pharmacol Physiol; 2008 Dec 15; 21(4):203-10. PubMed ID: 18509254
    [Abstract] [Full Text] [Related]

  • 20. Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis.
    Jordon RE, Rapini RP, Rex IH, Katz HI, Hickman JG, Bard JW, Medansky RS, Lew-Kaya DA, Sefton J, DeGryse RE.
    Int J Dermatol; 1990 Dec 15; 29(6):441-2. PubMed ID: 2397973
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.